CPT vs ERNA · P/E 104, rev $7.1M vs P/E 0.0, rev $582.0K
Camden Property Trust (CPT) versus Eterna Therapeutics Inc (ERNA) — a side-by-side from cached financials, not a winner call.
Camden Property Trust (CPT) is a reit - residential company listed on US.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Latest reported CPT revenue for 2024-12-31 was $7.1M. Net income was $170.8M. Revenue was up 106.8% from 2023-12-31 to 2024-12-31. CPT currently screens at market cap $12.11B and trailing P/E 104.0.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
CPT currently screens at market cap $12.11B and trailing P/E 104.0. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Not investment advice. Open the CPT and ERNA stock pages for the full models.
Not investment advice.